TAGLIALATELA, MAURIZIO
 Distribuzione geografica
Continente #
AS - Asia 7.800
NA - Nord America 6.145
EU - Europa 4.905
SA - Sud America 1.127
AF - Africa 170
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 20.154
Nazione #
US - Stati Uniti d'America 5.824
SG - Singapore 3.566
RU - Federazione Russa 2.245
VN - Vietnam 1.494
CN - Cina 1.326
IT - Italia 1.010
BR - Brasile 892
HK - Hong Kong 688
FR - Francia 287
DE - Germania 279
FI - Finlandia 235
CA - Canada 197
NL - Olanda 186
GB - Regno Unito 137
UA - Ucraina 129
JP - Giappone 115
IN - India 109
IE - Irlanda 104
AR - Argentina 97
MX - Messico 80
BD - Bangladesh 75
SE - Svezia 64
PL - Polonia 59
KR - Corea 52
TH - Thailandia 47
AT - Austria 43
ID - Indonesia 42
IQ - Iraq 39
PH - Filippine 39
ZA - Sudafrica 38
EC - Ecuador 36
ES - Italia 30
PK - Pakistan 28
CO - Colombia 25
TR - Turchia 25
VE - Venezuela 23
EG - Egitto 21
CI - Costa d'Avorio 20
PY - Paraguay 19
TW - Taiwan 18
MA - Marocco 15
UZ - Uzbekistan 15
BE - Belgio 14
DZ - Algeria 14
SA - Arabia Saudita 13
IL - Israele 12
JO - Giordania 12
OM - Oman 12
CL - Cile 11
UY - Uruguay 11
AZ - Azerbaigian 10
GR - Grecia 10
JM - Giamaica 10
NP - Nepal 10
LB - Libano 9
RS - Serbia 9
BG - Bulgaria 8
PE - Perù 8
IS - Islanda 7
TN - Tunisia 7
AL - Albania 6
ET - Etiopia 6
KE - Kenya 6
BW - Botswana 5
CZ - Repubblica Ceca 5
IR - Iran 5
LT - Lituania 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
BY - Bielorussia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
GH - Ghana 4
KZ - Kazakistan 4
PS - Palestinian Territory 4
PT - Portogallo 4
CR - Costa Rica 3
CY - Cipro 3
DK - Danimarca 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
MD - Moldavia 3
ML - Mali 3
NG - Nigeria 3
NI - Nicaragua 3
PR - Porto Rico 3
AF - Afghanistan, Repubblica islamica di 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BZ - Belize 2
CG - Congo 2
EE - Estonia 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
Totale 20.096
Città #
Singapore 1.639
San Jose 1.005
Hong Kong 662
Moscow 568
Ashburn 480
Ho Chi Minh City 395
Chandler 384
Beijing 348
Hanoi 308
Millbury 265
Naples 229
The Dalles 229
Hefei 218
Lauterbourg 200
Los Angeles 196
Santa Clara 191
Princeton 187
Jacksonville 159
Amsterdam 133
Dallas 125
Ottawa 121
Nanjing 104
Dong Ket 93
Tokyo 90
Buffalo 87
Redondo Beach 85
Des Moines 83
São Paulo 78
Boston 76
New York 76
Napoli 75
Haiphong 66
Munich 60
Da Nang 58
Milan 58
Wilmington 58
Seattle 57
Council Bluffs 55
Orem 40
Houston 39
Nanchang 37
Seoul 37
Marano di Napoli 35
Atlanta 34
Norwalk 34
Warsaw 34
Formia 33
Mexico City 32
Frankfurt am Main 31
Nuremberg 31
Shenyang 30
Chicago 29
Montreal 29
Guangzhou 28
Lawrence 26
Hải Dương 24
Johannesburg 24
Turku 24
Brasília 23
Brooklyn 23
Hebei 23
Belo Horizonte 22
Tianjin 22
Washington 22
Biên Hòa 21
London 20
Chennai 19
Phoenix 19
Vienna 18
Denver 17
Dublin 17
Helsinki 17
Jiaxing 17
Breda 16
Rome 16
San Francisco 16
Stockholm 16
Toronto 16
Trentola-Ducenta 16
Bangkok 15
Gdansk 15
Poplar 15
Bắc Ninh 14
Can Tho 14
Changsha 14
Curitiba 14
Falkenstein 14
Lappeenranta 14
Vancouver 14
Verona 14
Campinas 13
Falls Church 13
Manchester 13
Ninh Bình 13
Rio de Janeiro 13
Baghdad 12
Kunming 12
Quito 12
Charlotte 11
Florence 11
Totale 10.608
Nome #
Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant Activity 189
A novel hyperekplexia-causing mutation in the pre-trasmembrane segm 1 of the human glycine receptor alpha 1 subunit reduces membrane expression and impairs gating by agonists 183
Kv7 channel activation reduces brain endothelial cell permeability and prevents kainic acid-induced blood-brain barrier damage 176
“One Health” Approach for Health Innovation and Active Aging in Campania (Italy) 167
Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions 157
Tryptamine-based derivatives as Transient Receptor Potential Melastatin type-8 (TRPM8) channel modulators 153
Differential expression of the Na+-Ca2+ exchanger transcripts and proteins in rat brain regions. 153
Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes. 151
A micro-bioimpedance meter for monitoring insulin bioavailability in personalized diabetes therapy 151
Effects of manidipine and nitrendipine enantiomers on the plateau phase of K+-induced intracellular Ca2+ increase in GH3 cells. 147
Insights into the pathogenesis of ATP1A1-related CMT disease using patient-specific iPSCs 146
Expression pattern of the ether-a-gogo-related (ERG) k+ channel-encoding genes ERG1, ERG2, and ERG3 in the adult rat central nervous system 142
A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability 142
The voltage-sensing domain of Kv7.2 channels as a molecular target for epilepsy-causing mutations and anticonvulsants 142
Decreased Subunit Stability as a Novel Mechanismfor PotassiumCurrent Impairment by a KCNQ2 C Terminus Mutation Causing Benign Familial Neonatal Convulsions 141
Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity. 138
A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy 138
Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits 138
Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene. 136
Driving with no brakes: Molecular pathophysiology of Kv7 potassium channels 136
Generation of an iPSC line (UNINAi001-A) from a girl with neonatal-onset epilepsy and non-syndromic intellectual disability carrying the homozygous KCNQ3 p.PHE534ILEfs*15 variant and of an iPSC line (UNINAi002-A) from a non-carrier, unaffected brother 136
Differential expression of the Na+-Ca2+ exchanger transcripts and proteins in rat brain regions 134
Pure uptake blockers of dopamine can reduce prolactin secretion: studies with diclofensine 134
Caratterizzazione biochimica e funzionale in oociti di Xenopus Laevis e cellule CHO (Chinese Hamster Ovary Cells) di mutazioni nel gene Kcnq2 riscontrate in famiglie affette da convulsioni benigne neonatali 134
M Channels Containing KCNQ2 Subunits Modulate Norepinephrine, Aspartate, and GABA Release from Hippocampal Nerve Terminals 132
A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes 132
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators 132
Neuronal potassium channel openers in the management of epilepsy: Role and potential of retigabine 131
Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species 130
Autism and developmental disability caused by KCNQ3 gain-of-function variants 130
Differential Vulnerability of Cortical and Cerebellar Neurons in Primary Culture to Oxygen Glucose Deprivation followed by Reoxygenation. 129
Genotype-phenotype correlations in patients with de novo KCNQ2 pathogenic variants 129
Expression pattern of the ether-a-gogo-related (ERG) K+ channel-encoding genes ERG1, ERG2, and ERG3 in the adult rat central nervous system. 128
GAIN-OF-FUNCTION DUE TO INCREASED OPENING PROBABILITY BY TWO KCNQ5 PORE VARIANTS CAUSING DEVELOPMENTAL AND/OR EPILEPTIC ENCEPHALOPATHY 128
Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels 127
A novel mutation in KCNQ2 associated to BFNC, drug resistant epilepsy and mental retardation 125
Cardiac safety of second-generation H1 -antihistamines when updosed in chronic spontaneous urticaria 125
Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures 123
Human ether-a-gogo related gene (HERG) K+ channels as pharmacological targets: present and future implications 123
Expression, Localization, and Pharmacological Role of Kv7 Potassium Channels in Skeletal Muscle Proliferation, Differentiation, and Survival after Myotoxic Insults 122
KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism 121
Identification of Drugs Acting as Perpetrators in Common Drug Interactions in a Cohort of Geriatric Patients from Southern Italy and Analysis of the Gene Polymorphisms That Affect Their Interacting Potential 121
A y(+)LAT-1 mutant protein interferes with y(+)LAT-2 activity: implications for the molecular pathogenesis of lysinuric protein intolerance. 121
Brain distribution of the Na+/Ca2+ exchanger-encoding genes NCX1, NCX2, and NCX3 and their related proteins in the central nervous system 120
Specification of skeletal muscle differentiation by repressor element-1 silencing transcription factor (REST)-regulated Kv7.4 potassium channels 119
Up-regulation and increased activity of KV3.4 channels and their accessory subunit MinK-related peptide 2 induced by amyloid peptide are involved in apoptotic neuronal death 116
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction 116
Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions 115
Addressing the use of PDIF-CN2 molecules in the development of n-type organic field-effect transistors for biosensing applications 114
Modulation of ion channels by reactive oxygen and nitrogen species: a pathophysiological role in brain aging? 113
Gating currents from Kv7 channels carrying neuronal hyperexcitability mutations in the voltage-sensing domain 113
Non-invasive real-time in-vivo monitoring of insulin absorption from subcutaneous tissues 113
Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs). 112
Coupling between the voltage-sensing and phosphatase domains of Ci-VSP 112
Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels 111
Blockade of herg K+ channels by second-generation H1 receptor-antagonists may regulate [Ca2+]i oscillations in GH3 cells 111
Human neoplastic mesothelial cells express voltage-gated sodium channels involved in cell motility 110
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines 110
Vasorelaxation by hydrogen sulphide involves activation of Kv7 potassium channels 110
Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of Kv7.2 potassium channel subunits 110
Molecular basis for the cardiovascular adverse effects of the first- and second-generation antihistamines. 109
Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity 109
Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC) 108
Paracetamol and ibuprofen fixed-dose combination for the management of acute mild-to-moderate pain in children: strengthening and enhancing of result of Nominal Group Technique through Delphi consensus 107
Activation of pre-synaptic M-type K+ channels inhibits [3H]D-aspartate release by reducing Ca2+ entry through P/Q-type voltage-gated Ca2+ channels 107
Early treatment with quinidine in two patients with epilepsy of infancy with migrating focal seizures (EIMFS) due to gain-of-function KCNT1 mutations: functional studies, clinical responses and critical issues for personalized therapy 106
IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells 106
Fluoxetine Treatment in Epilepsy of Infancy with Migrating Focal Seizures Due to KCNT1 Variants: An Open Label Study 105
Pharmacological blockade of ERG K+ channels and Ca2+ influx through store-operated channels exerts opposite effects on intracellular Ca2+ oscillations in pituitary GH3 cells 105
Plasma prolactin levels in the inferior petrosal sinuses in various pituitary disorders during perihypophyseal phlebography 105
KCNT2-related disorders: phenotypes, functional and pharmacological properties 104
Epidemiological and Immune Profile Analysis of Italian Subjects with Endometriosis and Multiple Sclerosis 104
Manidipine and Nitrendipine R and S enantiomers block voltage-gated Ca2+ channel (VGCC) with different kinetic in GH3 cell 104
Gender-related issues in the pharmacology of new anti-obesity drugs 104
Histidines 578 and 587 in the S5-S6 linker of the human Ether-a-gogo Related Gene-1 K+ channels confer sensitivity to reactive oxygen species 103
Pharmacological Targeting Of Neuronal Kv7.2/3 Channels: A Focus On Chemotypes And Receptor Sites 103
Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs). 101
A Novel Kv7.3 Variant in the Voltage-Sensing S4 Segment in a Family With Benign Neonatal Epilepsy: Functional Characterization and in vitro Rescue by β-Hydroxybutyrate 101
Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors 100
Maitotoxin, a novel activator of mediator release from human basophils, induces large increases in cytosolic calcium resulting in histamine, but not leukotriene C4, release. 100
Critical role of large-conductance calcium- and voltage-activated potassium channels in leptin-induced neuroprotection of N-methyl-d-aspartate-exposed cortical neurons 100
New advances in beta-blocker therapy in heart failure 100
A new Italian FHM2 family: Clinical aspects and functional analysis of the disease-associated mutation 99
Targeting Kv7 Potassium Channels for Epilepsy 98
Gating consequences of charge neutralization of arginine residues in the S4 segment of K(v)7.2, an epilepsy-linked K+ channel subunit 98
Domperidone antagonizes bromoergocriptine--induced nausea and vomiting without affecting its inhibition of prolactin secretion in puerperal women. 98
Prolonged exposure of pituitary dopaminergic receptors to the phospholipid phosphatidylserine increases their sensitivity to dopamine in aged rats 98
K(V)7 channels regulate muscle tone and nonadrenergic noncholinergic relaxation of the rat gastric fund 98
Potassium current inactivation as a novel pathomechanism for KCNQ2 developmental and epileptic encephalopathy 97
Neurobiology of coronaviruses: Potential relevance for COVID-19 97
Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants 97
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 96
A pharmacological study on the possible mechanisms underlying changes in TSH secretion in aged male rats 96
Ibopamine-induced reduction of serum prolactin level and milk secretion in puerperal women. 95
Gating currents from neuronal KV7.4 Channels: General features and correlation with the ionic conductance 95
De novo variants in KCNA3 cause developmental and epileptic encephalopathy 94
Pre-synaptic BK channels selectively control glutamate versus GABA release from cortical and hippocampal nerve terminals 94
The Na+-Ca++ exchanger in central nerve endings: the relationship between its pharmacological blockade and dopamine release from tuberoinfundibular hypothalamic neurons 92
Kv7.4 channels regulate potassium permeability in neuronal mitochondria 92
Protein-tyrosine kinases activate while protein-tyrosine phosphatases inhibit L-type calcium channel activity in pituitary GH3 cells. 91
Totale 11.914
Categoria #
all - tutte 66.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202195 0 0 0 0 0 0 0 0 0 0 0 95
2021/20221.029 14 7 5 14 15 33 10 38 120 62 213 498
2022/20231.166 229 118 21 148 135 98 8 73 150 132 44 10
2023/2024826 40 93 97 52 60 79 22 71 19 17 189 87
2024/20255.430 306 359 27 50 104 215 726 339 432 531 1.749 592
2025/202610.176 1.123 808 1.166 953 1.545 355 1.169 655 1.457 595 249 101
Totale 20.500